This fictional teaching case examines a med spa with $1.65 million revenue and an expired oversight agreement. Rebuilding the operating budget reduces normalized EBITDA from $278,000 to $217,000. The example separates legal remediation from pricing, then follows an assumed $858,000 offer through debt, expenses, escrow, and a hypothetical tax reserve.
What is the fictional problem?
Assume a med spa reports $1.65 million annual earned revenue and $278,000 EBITDA. During diligence, the buyer finds that the written medical director agreement expired. The seller says clinical support continued informally, but the file does not yet establish who performed which duties or what arrangements supported them.
This is the start of an investigation, not proof of a particular violation. Counsel needs the state, ownership, services, provider licenses, actual supervision, prescribing practices, agreements, and timeline. The parties should avoid describing the gap as harmless simply because the business kept operating, or declaring the entire operation unlawful from one missing document.
Which facts need to be established before discussing a discount?
Create a chronology of the agreement, renewal discussions, invoices, coverage, credential changes, service additions, and responsibilities. Interview the appropriate people through counsel and compare their explanations with contemporaneous records. A newly signed agreement cannot by itself establish that historical obligations were satisfied.
The California Medical Board’s practice guidance identifies professional-control issues for California. It does not provide a universal management-company structure or validate this fictional business. Local healthcare counsel must determine the applicable requirements and any reporting, corrective, or transaction consequences.
Do not send identifiable patient charts into a general deal room to prove that care occurred. Establish a lawful review method and preserve original records. The HIPAA definitions in 45 CFR 160.103 help identify regulated roles but do not authorize every requested disclosure. Historical review and buyer access require their own scope and safeguards.
How does the recurring cost budget change earnings?
Assume the buyer’s supported future structure needs $42,000 annual oversight cost and $19,000 recurring administrative coordination beyond expenses already recorded. These are incremental amounts; the teaching case assumes they are not already embedded in the $278,000 EBITDA.
| Item | Annual amount |
|---|---|
| Reported EBITDA | $278,000 |
| Additional oversight cost | −$42,000 |
| Additional coordination cost | −$19,000 |
| Normalized EBITDA | $217,000 |
The $61,000 adjustment describes recurring economics under an assumed support plan. It does not establish what a particular medical director should be paid, what services can be delegated, or whether an agreement meets local requirements. Verify duties, capacity, compensation basis, and the actual arrangement before treating the budget as usable.
What happens to the hypothetical valuation range?
Suppose an early discussion used an invented 4.1 factor against reported EBITDA: $278,000 × 4.1 = $1,139,800. The same factor applied to corrected earnings gives $889,700. Using an invented lower sensitivity factor of 3.7 gives $802,900.
The $802,900 to $889,700 interval is arithmetic for this example, not an observed med spa market range. Assume the parties discuss $858,000 consideration. That is $281,800 below the earlier $1,139,800 illustration, but the difference is not evidence that agreement gaps always produce this discount.
Separate a changed earnings denominator from a changed risk assessment. If recurring costs explain part of the difference, do not also apply a vague duplicate penalty without identifying what remains unresolved. Conversely, a comfortable price cannot replace legal feasibility, qualified coverage, patient continuity, or the buyer’s ability to operate.
Which one-time costs should stay outside recurring EBITDA?
Assume $37,000 one-time remediation spending is needed for document review, implementation, and transition work. The amount is fictional and does not represent a legal fee quote or guarantee that all issues can be cured. Counsel may identify a different path, additional obligations, or a reason not to proceed.
Keep this spending separate from the $61,000 annual correction. Subtracting $37,000 every year would misstate recurring earnings. Ignoring it in cash planning would also be wrong. The agreement should specify who pays, when the work occurs, and what evidence establishes completion.
Possible closing conditions should be drafted around supported outcomes: approved arrangements, required consents, qualified staffing, verified authority, records responsibility, and a practical handover. Do not use a broad promise to comply after closing as a substitute for identifying what must already be true on the transfer date.
How much cash could the seller receive immediately?
Assume $858,000 total consideration consists of $772,200 closing cash and an $85,800 seller note. Deduct $101,000 existing debt, $46,000 transaction fees, $64,000 escrow, and the separate $37,000 remediation budget. Cash available before taxes is $524,200.
An arbitrary $109,000 tax-planning reserve leaves $415,200 unreserved immediate cash. The reserve is neither an estimated tax liability nor an implied tax rate. The IRS guidance on selling a business explains why asset allocation and tax character matter. A CPA must model the actual entity, basis, assets, payment structure, and jurisdiction.
The $85,800 note and $64,000 escrow remain separate exposures. They are not additional cash available at closing. The seller should understand repayment rights, security, offsets, release conditions, and how unresolved matters affect collection rather than treating the headline as a guaranteed deposit.
What decisions should the buyer make before signing?
- Define the unresolved legal and operational questions with qualified counsel.
- Establish the actual historical timeline and preserve evidence.
- Budget a supported future clinical and administrative structure.
- Verify that recurring costs are incremental and complete.
- Allocate one-time spending and require appropriate closing evidence.
- Reassess funding, downside cash, and the option to stop.
The buyer should give each open issue an owner, deadline, consequence, and evidence requirement. “Legal to review” is not a finished workstream. A timetable should allow real investigation rather than forcing reviewers to endorse a preferred closing date.
Any lender needs the corrected facts and budget. Describing the original earnings while withholding a newly identified recurring expense can undermine the transaction. A financing assumption is not a commitment and does not establish that the clinical structure is acceptable.
What should the first post-closing month confirm?
Assuming the transaction proceeds, verify that the approved arrangement operates in practice: responsible professionals are available, staff understand escalation, invoices match the budget, and administrative permissions respect clinical decision rights. A signed document and a financial adjustment are not the end of implementation. Keep a dated record of unresolved items and the person responsible for follow-up.
Review actual recurring costs against the $61,000 incremental assumption without describing every variance as failure. The final arrangement may require a different budget. Update projections and reserve needs promptly, and distinguish ordinary implementation spending from a newly discovered historical concern requiring professional review.
How can the seller improve the decision without making unsupported assurances?
Provide complete records, distinguish known facts from recollections, and authorize the appropriate professional review. Avoid promises that a new document will eliminate every historical concern or that the buyer can simply retain the seller’s current arrangement. Authority, consent, and actual performance matter.
Use the seller roadmap, buyer hub, valuation guidance, and operations hub to connect the workstreams. The medical director agreement guide supports document review, while the Four-Number Med Spa Valuation Screen keeps the earnings correction visible.
Apply the offer-to-proceeds bridge after the proposed terms change. The lesson is a sequence: establish a supportable operation, model its recurring economics, allocate transition costs, and then decide whether the price and remaining obligations make sense.
What else do owners and buyers ask?
Does an expired agreement automatically make a med spa unsellable?
No universal conclusion follows from one expired document. The actual state, services, ownership, professional roles, historical performance, and applicable requirements must be investigated. Some findings may be resolvable; others may prevent the proposed transaction. Qualified healthcare counsel should identify the consequences before the parties rely on a revised price or replacement agreement.
Can the buyer solve the issue by paying less?
A price adjustment changes economics, not legal authority or professional responsibilities. The buyer still needs a supported structure, appropriate personnel, required consents, and a practical transition. If those conditions cannot be established, a discount does not make the operation viable. The example’s assumed value is a teaching calculation, not a cure.
Why separate recurring oversight from one-time remediation?
They affect different decisions. Recurring costs reduce the earnings available to support ongoing operations and financing. One-time implementation spending affects transaction funding and immediate proceeds. Confirm whether costs already appear in historical accounts, define who pays them, and avoid either subtracting the same expense twice or omitting a necessary cash use.
Is the $109,000 reserve a recommended tax allowance?
No. It is an arbitrary hypothetical assumption used to demonstrate cash planning. Actual taxes depend on transaction structure, asset allocation, basis, payment timing, jurisdiction, and the seller’s circumstances. A qualified tax adviser should calculate the real result and revise the model when the documents or proposed consideration change.
Which sources support this guide?
Sources were checked during research. Regulations, lender policies, and market conditions can change. Use the linked primary material and your advisors to confirm applicability.
- Professional control and practice transition guidance — Medical Board of California
- HIPAA definitions, 45 CFR 160.103 (2025 edition) — U.S. Government Publishing Office / HHS
- Sale of a business — Internal Revenue Service
Educational analysis prepared with AI-assisted research for The Med Spa Broker. “Last reviewed” records the source and editorial check date; it does not imply review by an attorney, clinician, or independent appraiser. Read our editorial standards.